Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: opioid

OA Patient-Reported Outcomes Positive for Intra-Articular Injection

Carina Stanton  |  January 21, 2019

In a recent Phase 2 clinical trial, patient-perceived pain and function measures improved with SM04690, an injectable, disease-modifying osteoarthritis treatment currently in development…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:intra-articular Wnt-β catenin inhibitorjoint injectionkneeknee osteoarthritisKnee Osteoarthritis (OA)SM04690

The Eliminating Kickbacks in Recovery Act of 2018—What Does It Mean?

Steven M. Harris, Esq.  |  January 17, 2019

It should not be a surprise to anyone that the U.S. is facing a national opioid crisis. It may be a surprise, however, that the federal government recently passed a law to address this crisis—a law that may have a profound impact on many healthcare facilities, some of which are not involved in the substance…

Filed under:Drug UpdatesLegal Updates Tagged with:opioid crisissubstance abuse

Patients with Prediabetes May Be Predisposed to Arthritis

Lara C. Pullen, PhD  |  January 2, 2019

New research from the CDC shows that approximately one-third of U.S. adults with prediabetes also have arthritis, which can prevent physical activity in these patients, thereby, making it more likely they will develop type 2 diabetes…

Filed under:Conditions

ACR Leaders Discuss E/M Coding Changes, Step Therapy & More

Thomas R. Collins  |  December 18, 2018

CHICAGO—ACR leaders described a series of looming legislative and regulatory threats to rheumatologists and their patients—including the proposed collapsing of evaluation and management (E/M) coding and potential changes to step therapy rules—and urged everyone in the field to make their voices heard to quash the proposals. They also recounted recent victories in the policy realm…

Filed under:Billing/CodingLegislation & AdvocacyMeeting Reports Tagged with:2018 ACR/ARHP Annual MeetingBiosimilarsE/M CodingH1B visasstep therapy

ah_designs / shutterstock.com

The Perils of Pain Meds Revisited

Stephen G. Gelfand, MD, FACP, FACR  |  December 18, 2018

More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

Filed under:Analgesics Tagged with:opioid crisis

Nonsurgical Therapies for Knee OA Pain: From Medications to Bracing to Exercise, What Works & What Doesn’t

Susan Bernstein  |  November 28, 2018

CHICAGO—Many nonsurgical therapies are available for knee osteoarthritis pain, but they vary greatly in effectiveness. “How should I proceed and figure out what to do with our patients?” asked David T. Felson, MD, MPH, professor of medicine at Boston University School of Medicine, during OA Management Without Surgery in 2018, a session at the 2018…

Filed under:American College of RheumatologyConditionsMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:2018 ACR/ARHP Annual Meeting

Cerebral Blood Flow Variability May Provide Insights into Fibromyalgia

Lara C. Pullen, PhD  |  November 20, 2018

Recent research demonstrated that fibromyalgia patients have lower cerebral blood flow velocity variability than healthy controls, which may reflect impaired coordination of cerebral regulatory systems. This analysis may be a promising tool for characterizing fibromyalgia pathology and understanding health-related quality of life…

Filed under:ConditionsPain Syndromes Tagged with:cerebral blood flow velocityFibromyalgiaPain

5-Year Data on Secukinumab in AS; Oliceridine Not Recommended for FDA Approval

Michele B. Kaufman, PharmD, BCGP  |  November 7, 2018

In a long-term study, secukinumab proved safe and effective for treating ankylosing spondylitis…

Filed under:AnalgesicsAxial SpondyloarthritisBiologics/DMARDsDrug Updates Tagged with:Ankylosing SpondylitisFDAoliceridinePainsecukinumabU.S. Food and Drug Administration (FDA)

ACR Leaders Outline Advocacy Victories, Threats

Thomas R. Collins  |  October 22, 2018

CHICAGO—ACR leaders described a series of looming legislative and regulatory threats to rheumatologists and their patients—including the proposed collapsing of evaluation and management (E/M) coding and potential changes to step therapy rules—and urged everyone in the field to make their voices heard to quash the proposals. They also recounted recent victories in the policy realm…

Filed under:American College of RheumatologyLegislation & AdvocacyMeeting Reports Tagged with:2018 ACR/ARHP Annual Meetingevaluation and management (E/M) codinglegislative and regulatory threatsstep therapy

The 2018 ACR/ARHP Annual Meeting Program Preview

From the College  |  September 20, 2018

Save the date for the 2018 ACR/ARHP Annual Meeting, Oct. 19–24 in Chicago. Connect with your colleagues for an unmatched educational experience featuring exceptional sessions by leading rheumatology experts. The ACR/ARHP Annual Meeting is your gateway to global rheumatology education. With more than 450 sessions—including The Great Debate—the meeting provides boundless opportunities for professional development,…

Filed under:From the College Tagged with:2018 ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)

  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 32
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences